Posted by Michael Wonder on 08 Mar 2026
Ottawa should allow all drugs approved in the EU and US to be marketed in Canada
7 March 2026 - The FederalGovernment plans to speed up some drug approvals in Canada by allowing Health Canada to make greater use of approval decisions from certain foreign regulators, such as the United States and European Union.
While the change is an improvement on the status quo, why stop there? Rather than continue the duplication of approval efforts, why not allow medical innovators access to the Canadian market as soon as their medicine is approved by these trusted foreign regulators?
To be clear, Canadians are not well served by the current federal regulatory regime and Health Canada’s monopoly in drug approvals in terms of timeliness and access.
